|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2019 |
|
FOR |
|
ENDOSYS DEVELOPMENTS LIMITED |
|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2019 |
|
FOR |
|
ENDOSYS DEVELOPMENTS LIMITED |
ENDOSYS DEVELOPMENTS LIMITED (BY SHARES) (REGISTERED NUMBER: 04196010) |
|
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 5 APRIL 2019 |
|
|
|
|
|
|
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
ENDOSYS DEVELOPMENTS LIMITED (BY SHARES) |
|
COMPANY INFORMATION |
FOR THE YEAR ENDED 5 APRIL 2019 |
|
|
|
|
|
|
|
DIRECTOR: |
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ENDOSYS DEVELOPMENTS LIMITED (BY SHARES) (REGISTERED NUMBER: 04196010) |
|
BALANCE SHEET |
5 APRIL 2019 |
|
5/4/19 | 5/4/18 |
£ | £ | £ | £ |
FIXED ASSETS |
|
|
|
CURRENT ASSETS |
|
|
|
CREDITORS |
Amounts falling due within one year | ( |
) | ( |
) |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CREDITORS |
Amounts falling due after more than one
year |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
|
|
|
NOTE TO THE FINANCIAL STATEMENTS |
|
1. | OTHER FINANCIAL COMMITMENTS |
|
Included within creditors is bank loan of £380,000 (2018: £400,000) which is secured by the way of legal charge |
over the company's investment property. The bank loan is repayable by quarterly instalments within 5 years with |
the rate of interest of 3% above base. |
|
Included within creditors is a loan from shareholder of £423,057 (2018: £448,057) which is interest free and with |
no specific terms of repayment. |
|
Included within creditors is an additional new loan from shareholder of £255,367 (2018: £263,520) which is |
repayable within 5 years with the rate of interest of 2.75% above base. |
|
|
|
|
|
|
|
The director acknowledges his responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
ENDOSYS DEVELOPMENTS LIMITED (BY SHARES) (REGISTERED NUMBER: 04196010) |
|
BALANCE SHEET - continued |
5 APRIL 2019 |
|
|
|
|
The financial statements were approved by the director on
|
|
|
|
|
|
|
|